No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ENGN enGene Holdings
- 5.830
- -0.130-2.18%
Close Dec 20 16:00 ET
297.19MMarket Cap-5.39P/E (TTM)
6.540High5.600Low99.16KVolume6.540Open5.960Pre Close584.15KTurnover0.34%Turnover RatioLossP/E (Static)50.98MShares18.40052wk High1.09P/B171.16MFloat Cap4.42052wk Low--Dividend TTM29.36MShs Float47.170Historical High--Div YieldTTM15.77%Amplitude4.420Historical Low5.890Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Engene Holdings Faces Regulatory Challenges and Business Risks Amid Clinical Trial Hurdles
JMP Securities Maintains EnGene Holdings(ENGN.US) With Buy Rating, Maintains Target Price $18
Positive Developments in EnGene Holdings' LEGEND Trial Support Buy Rating
Morgan Stanley Maintains EnGene Holdings(ENGN.US) With Buy Rating, Cuts Target Price to $37
Analysts Offer Insights on Real Estate Companies: Federal Realty (FRT), Real Brokerage (REAX) and EnGene Holdings (ENGN)
Promising Potential of EnGene Holdings' Detalimogene Voraplasmid in NMIBC Treatment: A Compelling Investment Opportunity
Heat List
US
Overall
Symbol
Price
% Chg
No Data